A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Clinical trial NCT05648500 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05648500
- Sponsor
- Viatris Innovation GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-13
- Primary completion
- 2026-10-31
- Enrollment
- 470
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.